Frequency Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Frequency Therapeutics is a biotechnology research company focused on regenerative medicine as a distinct area of practice. It aims to unlock the body's innate regenerative potential through a progenitor cell activation approach. Its lead preclinical program is designed to stimulate oligodendrocyte precursor cells to promote remyelination and potential functional recovery for people living with multiple sclerosis.

The company is based in Lexington, Massachusetts, operating within the biotechnology research sector and described as a smaller to mid-sized enterprise. A notable development in July 2023 was the announced merger with Korro Bio, reflecting strategic consolidation in the field.

Sign up for free to view info

Company overview Employee directory